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Background: αCaMKII plays central and essential roles in long-term potentiation (LTP), learning and memory.
αCaMKII is activated via binding with Ca2+/CaM in response to elevated Ca2+ concentration. Furthermore,
prolonged increase in Ca2+ concentration leads to the auto-phosphorylation of αCaMKII at T286, maintaining the
activation of αCaMKII even after Ca2+/CaM dissociation. Importantly, the active form of αCaMKII is thought to
exhibit conformational change. In order to elucidate the relationships between the interaction of αCaMKII with CaM
and the conformational change of αCaMKII, we generated molecular probes (YFP-αCaMKII with CFP-CaM and YFP-
αCaMKII-CFP) and performed time-lapse imaging of the interaction with CaM and the conformational change,
respectively, in living cells using FRET.
Results: The interaction of YFP-αCaMKII with CFP-CaM and the conformational change of YFP-αCaMKII-CFP were
induced simultaneously in response to increased concentrations of Ca2+. Consistent with previous predictions, high
levels of Ca2+ signaling maintained the conformational change of YFP-αCaMKII-CFP at the time when CFP-CaM was
released from YFP-αCaMKII. These observations indicated the transfer of αCaMKII conformational change from CaM-
dependence to CaM-independence. Furthermore, analyses using αCaMKII mutants showed that phosphorylation at
T286 and T305/306 played positive and negative roles, respectively, during in vivo interaction with CaM and further
suggested that CaM-dependent and CaM-independent conformational changed forms displays similar but distinct
structures.
Conclusions: Importantly, these structual differences between CaM-dependent and -independent forms of αCaMKII
may exhibit differential functions for αCaMKII, such as interactions with other molecules required for LTP and
memory. Our molecular probes could thus be used to identify therapeutic targets for cognitive disorders that are
associated with the misregulation of αCaMKII.
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Alpha-Ca2+/calmodulin-dependent protein kinase II
(αCaMKII), a brain-specific isoform of CaMKII, is a
serine/threonine kinase [1-7].
A large number of studies, including several focused
upon mouse genetics, have shown that αCaMKII plays
essential and central roles in long-term potentiation
(LTP), learning, memory [8-12] and emotional behavior* Correspondence: kida@nodai.ac.jp
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reproduction in any medium, provided the or[13,14]. αCaMKII contains an N-terminal catalytic do-
main that is a central regulatory domain including auto-
inhibitory and calmodulin (CaM) binding regions, and a
C-terminal association domain essential for the forma-
tion of a αCaMKII multi-complex. In the basal state,
αCaMKII is inactive owing to intra-molecular binding of
the auto-inhibitory domain to the catalytic domain
[15,16]. In response to an increase in intracellular Ca2+
concentration, αCaMKII becomes active by interacting
with Ca2+-bound CaM. Interaction of αCaMKII and
CaM leads to the conformational change of αCaMKII
(CaM-dependent active form) by dissociation of the
auto-inhibitory domain from the catalytic domain.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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interaction of αCaMKII with CaM results in the auto-
phosphorylation of threonine-286 (T286) [17-25]. An
important point to consider is that phosphorylation at
T286 is thought to stabilize the CaM-bound form of
αCaMKII (CaM-independent active form) and therefore,
prevents the inactivation of αCaMKII kinase activity even
after the dissociation of CaM [26,27]. Thus, αCaMKII func-
tions as a “memory molecule” for Ca2+ signaling pathways
by creating a CaM-independent (T286-phosphorylated) ac-
tive form from a CaM-dependent active form in order to
maintain kinase activity. In contrast, phosphorylation at
T305 and T306 play an inhibitory role in the interaction
with CaM [28,29]. Consequently, interactions with CaM,
along with auto-phosphorylation, appear to play key regula-
tory roles for αCaMKII activation.
Recent studies using a fluorescence resonance energy
transfer (FRET)-based technique generated a molecular
probe to detect the conformational change of αCaMKII
by fusing YFP and CFP to the N- or C- terminus of
αCaMKII, respectively, and have shown that conform-
ational change of αCaMKII was visualized and moni-
tored in living neurons and single dendritic spines
[30-34]. However, relationships between the interaction
of αCaMKII with CaM, and the conformational change
of αCaMKII, especially in regulating the switch from
CaM-dependent to -independent active forms upon
changes in Ca2+ concentration, within living cells remain
unclear. In order to understand the molecular dynamics
of αCaMKII activation in living cells, the present study
attempted to investigate the time-dependent activation
of αCaMKII following the application of drugs to HeLa
cells, SH-SY5Y cells and cortical neurons. FRET was
used to monitor both the interaction of αCaMKII with
CaM, and also the conformational change of αCaMKII.
Results and discussion
Characterization of αCaMKII fusion proteins
To monitor the interaction of αCaMKII with CaM, YFP
and CFP were fused with the N-terminus of αCaMKII and
CaM, respectively, resulting in the formation of YFP-
αCaMKII and CFP-CaM constructs. On the other hand, to
monitor the conformational changes of αCaMKII, YFP and
CFP were fused with N- and C-terminus of αCaMKII,
respectively, generating a YFP-αCaMKII-CFP construct
(Figure 1A).
We first examined the function of our αCaMKII-
fusion proteins. We showed that YFP-αCaMKII and
YFP-αCaMKII-CFP exhibited comparable Ca2+/CaM-
dependent and -independent kinase activities with WT-
αCaMKII in the presence and absence of Ca2+/CaM with
or without EGTA (Figure 1B). In addition, we showed
that our αCaMKII-fusion proteins exhibited comparable
levels of phosphorylation at T286 before and after theapplication of ionomycin (Ca2+ ionophore) compared to
WT-αCaMKII in HeLa cells expressing WT-αCaMKII or
αCaMKII-fusion proteins (Figure 1C).
The αCaMKII holoenzyme is composed of 8–12 subunits
(αCaMKIIs) and we next verified the complex formation of
αCaMKII fusion proteins. Gel filtration of COS-1 cell
extracts expressing WT-αCaMKII or αCaMKII-fusion pro-
teins successfully detected αCaMKII-fusion proteins (YFP-
αCaMKII: 81 kDa, YFP-αCaMKII-CFP: 109 kDa) in frac-
tions (more than 800 kDa) that exhibited larger complexes
compared to WT-αCaMKII, indicating that αCaMKII-
fusion proteins form a multimer (Figure 1D). Collectively,
these results strongly suggested that the αCaMKII-fusion
proteins used in the present study exhibited comparable
function to WT-αCaMKII.
Detecting interactions of αCaMKII with CaM and the
conformational change of αCaMKII by FRET
A previous study examined the conformational change
of αCaMKII upon changes in Ca2+ concentration in-
duced by ionomycin in HeLa cells [30]. Therefore, we
first tried to detect the interaction of YFP-αCaMKII with
CFP-CaM induced by an increase in intracellular Ca2+
concentration in HeLa cells using FRET. YFP/CFP emis-
sion ratios were measured before and after the applica-
tion of ionomycin in the presence or absence of KN-93,
an interaction inhibitor of αCaMKII with CaM, or its in-
active analog KN-92. Cells treated with ionomycin for 5
min exhibited higher emission ratios compared to non-
stimulated cells (Figure 2A, B). Notably, the increase in
emission ratio induced by ionomycin was blocked by
KN-93, but not by KN-92 (Figure 2A, B). We next
performed an acceptor photo-bleaching test [35]. The
FRET efficiency of ionomycin-treated cells was higher
than that of non-treated cells (Figure 2C). The observed
increase in FRET efficiency was also blocked by KN-93,
but not by KN-92 (Figure 2C, black bars). It is important
to note that YFP-αCaMKII (1–290), that lacks the C-
terminal region including CaM binding site and thereby,
does not interaction with CaM [36], and CFP-CaM did
not change in emission ratio and the FRET efficiency
after the application of ionomycin in HeLa cells (data
not shown). Taken together, these results strongly sug-
gest that the increased emission ratio and FRET effi-
ciency following ionomycin-application reflect the
interaction of YFP-αCaMKII with CFP-CaM.
We next tried to detect the conformational change of
YFP-αCaMKII-CFP in HeLa cells. Cells treated with
ionomycin exhibited a lower emission ratio and FRET
efficiency compared to non-treated cells. Notably, these
reductions in emission ratio and FRET efficiency were
blocked by KN-93, but not by KN-92 (Figure 2D–F).
These results suggest that the reduced emission ratio
and FRET efficiency observed following the application
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αCaMKII-CFP arising via interaction with CaM. It is im-
portant to note that the YFP-αCaMKII-CFP used in this
study exhibited similar molecular dynamics as that ob-
served with a previous study of Camui, which also led to
reductions in emission ratio and FRET efficiency in re-
sponse to increased Ca2+ concentration [30].
Collectively, our results suggest that our molecular
probes allowed us to monitor αCaMKII-CaM interaction,
and αCaMKII-conformational change, following the stimu-
lation of live cells by drugs in a real-time manner.Figure 1 Characterization of αCaMKII fusion proteins. (A) Schematic re
measured using [γ-32P]-ATP incorporated into autocamtide-2 using extracts
the absence or presence of Ca2+/CaM and EGTA (n = 3). (C) Auto-phospho
αCaMKII or αCaMKII fusion proteins were incubated with ionomycin (0.5 μM
αCaMKII or αCaMKII specific antibody, respectively. The graph shows relativ
ability of αCaMKII fusion proteins. COS-1 cells expressing WT-αCaMKII or αC
represents absorbance curves at 280 nm. Right panel shows Western blot a
fraction (fraction No. 32–44).Time lapse imaging of the activation of αCaMKII in
HeLa cells
We attempted to monitor the activation of αCaMKII in
HeLa cells by time lapse imaging. Figure 3A shows
changes in intracellular Ca2+ concentration following the
application of ionomycin. The increase in emission ratio
was observed within 30 sec of ionomycin application
and maintained throughout the period of monitoring, in-
dicating that ionomycin induced a long-term increase in
intracellular Ca2+ concentration. Figure 3B, 3C show
time lapse imaging (30 sec interval) of the interaction ofpresentation of αCaMKII fusion proteins. (B) Kinase activities were
of COS-1 cells expressing WT-αCaMKII or αCaMKII fusion proteins in
rylation at T286 of αCaMKII fusion proteins. COS-1 cells expressing WT-
) or DMSO and then Western blotting performed using phospho-T286
e ratio of phospho-αCaMKII/αCaMKII level (n = 3). (D) Complex forming
aMKII fusion proteins were examined by gel filtration. Left graph
nalyses assaying the amount of αCaMKII fusion proteins in each
Figure 2 Detection of the interaction of αCaMKII with CaM and resultant conformational changes of αCaMKII by FRET. (A, B, C)
Interaction of YFP-αCaMKII with CFP-CaM. (D, E, F) Conformational change of YFP-αCaMKII-CFP. (A, D) Images of typical YFP/CFP ratio before
(−iono) and 10 min after the application of ionomycin (0.5 μM) (+iono). KN-93 (2 μM) or KN-92 (2 μM) was incubated for 30 min before the
application of ionomycin. (B, E) Relative emission ratios before and after the application of ionomycin in the cytoplasm. 40–50 cells were
analyzed in each group. (C, F) FRET efficiency using acceptor photo-bleaching in the cytoplasm. 20–30 cells were analyzed in each group.
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changes of YFP-αCaMKII-CFP, respectively, before and
after the application of ionomycin. Similarly, emission
ratios from YFP-αCaMKII with CFP-CaM and YFP-
αCaMKII-CFP was maximally increased or decreased 30
sec after ionomycin application and was maintained at
maximal or minimal levels thereafter, respectively
(Figure 3B, C). These increased and decreased emission
ratios were maintained for at least 24 min (Additional
file 1: Figure S1A). Furthermore, time lapse imaging
every 1 sec revealed that the emission ratio was in-
creased or decreased within 5 sec and reached max-
imum or minimal levels, respectively, within just 30 secof ionomycin application (Additional file 1: Figure S1B).
Notably, pre-treatment with KN-93 abolished the
changes in the emission ratio induced by the application
of ionomycin (Figure 3B, C). These results indicated that
the interaction of YFP-αCaMKII with CFP-CaM, and
the conformational change of YFP-αCaMKII-CFP, were
induced immediately after ionomycin application and
continued during the period in which Ca2+ concentration
increased. It is important to note that YFP-αCaMKII-CFP
exhibited similar long-term conformational changes as ob-
served in a previous study [30].
To further clarify the dynamic regulation of αCaMKII-
activation in response to changes in Ca2+ concentration,
Figure 3 Time lapse imaging of αCaMKII activation in HeLa cells. (A) Changes in intracellular Ca2+ concentration measured using Fura2-AM.
Upper panels show images of typical 340 nm/380 nm ratio at each time point before and after ionomycin application. Lower graph shows
changes in relative 340 nm/380 nm ratio (open circle, ionomycin; filled circle, DMSO). Black bar shows the period of ionomycin application. 12–18
cells were analyzed in each group. (B, C) Changes in the interaction of YFP-αCaMKII with CFP-CaM (B) and the conformational change of YFP-
αCaMKII-CFP (C). Upper panels show images of typical YFP/CFP emission ratio before and after ionomycin application (upper images, –KN-93;
lower images, +KN-93). Lower graphs show changes in relative YFP/CFP emission ratio (open circle, ionomycin; filled circle, ionomycin with
KN-93). Black bar shows the period of ionomycin application. 9–13 cells were analyzed in each group. (D) Effect of removal of ionomycin by
wash out at 0.5 or 1 min following ionomycin application. Upper graph shows the interaction of YFP-αCaMKII with CFP-CaM (open circle, –wash;
triangle, 0.5 min; filled circle, 1 min). Lower graph shows the conformational change of YFP-αCaMKII-CFP (open circle, -wash; triangle, 0.5 min;
filled circle, 1 min). 10–12 cells were analyzed in each group. (E) Auto-phosphorylation at T286 of αCaMKII fusion proteins after ionomycin
application at each time point (0, 1, 5 and 10 min). Upper panel shows Western blot analyses analyzing the expression level of phospho-αCaMKII
fusion proteins and total-αCaMKII fusion proteins. Lower graph shows relative ratio of phospho-αCaMKII/αCaMKII levels (n = 3).
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Consistent with previous observations (Figure 3B, C),
the relative emission ratio from cells expressing YFP-
αCaMKII and CFP-CaM began to increase immediately
following the application of ionomycin (Figure 3D, upper
panel). However, this increased emission ratio gradually
returned to baseline levels following the removal of
inonomycin. Importantly, this decreasing emission ratio
curve from YFP-αCaMKII with CFP-CaM correlated
with that of Ca2+ concentration following the removal of
ionomycin (Additional file 1: Figure S1C), indicating that
the interaction of YFP-αCaMKII with CFP-CaM reflects
changes in intracellular Ca2+ concentration. Similarly,
cells expressing YFP-αCaMKII-CFP displayed a transient
reduction in emission ratio when ionomycin was applied
for 0.5 min (Figure 3D, lower panel). However, in the
case of ionomycin application for 1 min, the reducedemission ratio did not return to baseline levels and was
maintained at a point that was 70% of the minimum
level (Figure 3D, lower panel), even when the increased
emission ratio from YFP-αCaMKII with CFP-CaM
returned to the baseline. This was the case even after
dissociation of CFP-CaM from YFP-αCaMKII, or after
the release of CFP-CaM from YFP-αCaMKII (Figure 3D,
upper panel), suggesting that YFP-αCaMKII-CFP exhibited
CaM-independent conformational change during this stage.
This observation supported previous predictions stating
that αCaMKII exhibits CaM-independent conformational
change even after the dissociation of CaM from αCaMKII
when prolonged increases in Ca2+ concentration leads to
the auto-phosphorylation of αCaMKII at T286. In contrast,
a comparison of the results in Figure 3 (3B VS 3C, D upper
panel VS lower panel) indicated that changes in emission
ratios from YFP-αCaMKII with CFP-CaM and YFP-
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first 0–5 min after ionomycin application, suggesting that
YFP-αCaMKII-CFP displayed CaM-dependent conform-
ational change during this stage.
In a manner similar to endogenous αCaMKII,
auto-phosphorylation levels of YFP-αCaMKII and YFP-
αCaMKII-CFP at T286 increased with time following the
application of ionomycin (Figure 3E, data not shown). More
importantly, when ionomycin was applied for 1 min, but
not 30 sec, increased levels of T286-phosphorylation were
sustained even 10 min after the removal of ionomycin
(Figure 3E, data not shown), supporting our conclusion that
auto-phosphorylation of YFP-αCaMKII-CFP at T286 con-
tributed to CaM-independent conformational change after
the dissociation of CaM.
Time lapse imaging of the activation of αCaMKII in SH-
SY5Y cells
We next attempted to examine the dynamics of
αCaMKII activation in neurons. To do this, we first im-
aged αCaMKII activation in SH-SY5Y cells, human
neuroblastoma cells, which are referred to as having
neuron-like physiology. We observed an increase in
Ca2+ concentration within 30 sec of ionomycin applica-
tion (Figure 4A). However, in contrast to the results
obtained using HeLa cells, this increased Ca2+ concen-
tration returned to baseline levels within 10 min. We
further characterized Ca2+ dynamics in SH-SY5Y cells
using KCl which induces an increase in Ca2+ concentra-
tion via depolarization in a similar manner to physio-
logical conditions. Similarly, transient increases in Ca2+
concentration were observed following the application of
KCl, although these levels of Ca2+ concentration were
lower than that induced by ionomycin and returned to
baseline within 3 min (Figure 4A). These results indi-
cated that Ca2+ dynamics following drug application
exhibited cell-type specificity.
In Figure 4B and C, we observed similar time-course
changes in emission ratios from YFP-αCaMKII with
CFP-CaM and YFP-αCaMKII-CFP in the presence of
ionomycin to those obtained from HeLa cells treated
with ionomycin for 1 min (Figure 3D); emission ratios
from YFP-αCaMKII-CFP was maintained at a reduced
level even after the increased emission ratios from
YFP-αCaMKII with CFP-CaM returned to the baseline.
These results suggest that YFP-αCaMKII-CFP exhibits
CaM-dependent conformational change and then CaM-
independent conformational change (Figure 4C). In
contrast, when SH-SY5Y cells were treated with KCl,
emission ratios from YFP-αCaMKII with CFP-CaM, and
YFP-αCaMKII-CFP were either increased or decreased,
respectively, but both returned to their respective base-
line (Figure 4B VS 4C), suggesting that YFP-αCaMKII-
CFP exhibited CaM-dependent conformational changebut failed to display a CaM-independent form. Import-
antly, changes in emission ratios from YFP-αCaMKII
with CFP-CaM, and YFP-αCaMKII-CFP following KCl
application were smaller than those induced by
ionomycin application (Figure 4B, C). This observation
appears to reflect a lower increase of intracellular
Ca2+ concentration by KCl compared to ionomycin
(Figure 4A).
Phosphorylation of αCaMKII-fusion proteins at T286
was increased following the application of ionomycin
or KCl (Figure 4D). However, the level of T286-
phosphorylation in response to ionomycin was higher
than that by KCl. Furthermore, the increased level of
T286-phosphorylation by ionomycin was maintained,
while this phosphorylation induced by KCl was kept at
the lower level (Figure 4D). These observations suggest
that CaM-independent conformational changes of YFP-
αCaMKII-CFP led by the application of ionomycin re-
flect prolonged phosphorylation at T286. In contrast,
the observation that the application of KCl failed to lead
to CaM-independent conformational change in YFP-
αCaMKII-CFP is thought to reflect the lower level and
transient increase of T286-phosphorylation.
Monitoring of the molecular dynamics of αCaMKII in
living cortical neurons
We finally examined the dynamics of αCaMKII in living
neurons. We observed similar changes in emission ratio
and FRET efficiency in the soma and dendrites of cor-
tical neurons expressing YFP-αCaMKII with CFP-CaM,
or YFP-αCaMKII-CFP to those of HeLa cells (Figures 2
and 5A–D). Consequently, we performed time-lapse
imaging of αCaMKII-activation in cortical neurons
(Figure 5E, F). Changes in emission ratios from YFP-
αCaMKII with CFP-CaM and YFP-αCaMKII-CFP were
inversely correlated in the presence of ionomycin; both
emission ratios changed but did not returned to baseline
levels (Figure 5E, F). Thus, cortical neurons exhibited
interaction of YFP-αCaMKII with CFP-CaM and con-
formational change of YFP-αCaMKII-CFP, following the
application of ionomycin.
We next examined the molecular dynamics of
αCaMKII activation upon an increase in Ca2+ concentra-
tion mediated by the NMDA receptor which plays essen-
tial roles in synaptic plasticity in neurons. To do this, we
examined the effects of applying NMDA. As with HeLa
cells (Figure 3), the long-term application of NMDA
increased or decreased emission ratios from YFP-
αCaMKII with CFP-CaM or YFP-αCaMKII-CFP, respect-
ively (Figure 5G, H). These changes in emission ratios
were maintained throughout imaging, suggesting that
long-term NMDA-application prolonged the interaction
of YFP-αCaMKII with CFP-CaM and the conformational
change of YFP-αCaMKII-CFP. In contrast, when NMDA
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emission ratios from YFP-αCaMKII with CFP-CaM
retuned to baseline. Furthermore, while the reduced
emission ratio from YFP-αCaMKII-CFP was increased, it
did not return to baseline levels. As with our previous
observations, these results suggest that YFP-αCaMKII-
CFP exhibits CaM-dependent conformational change
and then CaM-independent conformational change fol-
lowing the removal of NMDA. Importantly, the co-
application of AP5, a known blocker of the NDMAFigure 4 Time lapse imaging of αCaMKII activation in SH-SY5Y cells. (
AM. Upper panels show images of typical 340 nm/380 nm ratio at each tim
application. Lower graph shows changes in relative 340 nm/380 nm ratio (
ionomycin or KCl application. 30–40 cells were analyzed in each group. (B,
the conformational change of YFP-αCaMKII-CFP (C). Upper panels show im
KCl application. Lower graphs show changes in relative YFP/CFP emission r
period of ionomycin or KCl application. 11–25 cells were analyzed in each
after ionomycin or KCI application at each time point (0, 1, 5 and 10 min).
level of phospho-αCaMKII fusion proteins and total-αCaMKII fusion proteins
levels (n = 3).receptor, abolished the changes in emission ratios fol-
lowing NMDA application, indicating that changes in
emission ratio observed after NMDA application were
mediated by the NMDA receptor.
Effects of mutations at T286/305/306 upon the molecular
dynamics of CaMKII
We finally examined the effects of mutating αCaMKII at
T286 to alanine (A) or aspartate (D) in SH-SY5Y cells.
The T286A mutant can bind with CaM but is notA) Changes in intracellular Ca2+ concentration measured using Fura2-
e point before and after the application of ionomycin or KCl (50 mM)-
open circle, ionomycin; filled circle, KCl). Black bar shows the period of
C) Changes in the interaction of YFP-αCaMKII with CFP-CaM (B) and
ages of typical YFP/CFP emission ratio before and after ionomycin or
atio (open circle, ionomycin; filled circle, KCl). Black bar shows the
group. (D) Auto-phosphorylation at T286 of αCaMKII fusion proteins
Upper panel shows Western blot analyses analyzing the expression
. Lower graph shows relative ratio of phospho-αCaMKII/αCaMKII
Figure 5 (See legend on next page.)
Kato et al. Molecular Brain 2013, 6:37 Page 8 of 14
http://www.molecularbrain.com/content/6/1/37
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Figure 5 Monitoring the molecular dynamics of αCaMKII in living cortical neurons. (A, C) Typical images of the interaction of YFP-αCaMKII
with CFP-CaM (A) and the conformational change of YFP-αCaMKII-CFP (C) in the cytoplasm (upper panels) and dendrite (lower panels) before
and after ionomycin application (0.5 μM) for 10 min. Monochrome images show YFP fluorescence. (B, D) Left graphs show relative emission ratio
and right graphs show FRET efficiencies before (white bars) and after (black bars) ionomycin application. Upper graphs show the results of
cytoplasm. Lower graphs show the results of dendrites. (E, F) Changes in relative emission ratio following the application of ionomycin or KCl
(open circle, ionomycin; filled circle, KCl). Black bar shows the period of ionomycin or KCl application. 9–10 cells were analyzed in each group. (G,
H) Effect of short or long-term activation of NMDA receptor by the application of NMDA (25 μM) with or without pre-treatment of AP5 (25 μM)
(open circle, long-term; gray circle, short-term; filled circles, long-term with pre-treatment of AP5). Black bar and white bar show the period of
NMDA application. 7–9 cells were analyzed in each group.
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mimics the T286-phosphorylated form and functions as
a constitutive active form of αCaMKII. Emission ratios
from YFP-T268A with CFP-CaM and YFP-T268A-CFP
showed much smaller increases or decreases, respect-
ively, following the application of ionomycin compared
to control fusion proteins (Figure 6A, B). That emission
ratios from YFP-T268A-CFP returned to the baseline
was not surprising because this mutant is not phosphor-
ylated at T286, and thus lacks the ability to undergo
CaM-independent conformational change. More import-
antly, the observation that emission ratios from YFP-
T286A with CFP-CaM exhibited much smaller reduc-
tions compared to control fusion proteins indicates that
T286-phosphorylation is not only required for CaM-
independent conformational change but also plays regu-
latory roles in the interaction with CaM and supports
the hypothesis that phosphorylation at T286 stabilizes
the binding of CaM with αCaMKII [26,27]. On the other
hand, YFP-T286D with CFP-CaM exhibited increased
emission ratios immediately following the application of
ionomycin but more importantly, faster reductions in
emission ratios compared to control fusion proteins,
suggesting that the T286D mutation enhanced the dis-
sociation of CaM (Figure 6C, D). It is possible that the
constitutive kinase activation of the T286D mutant en-
hances phosphorylation at T305/306, thereby facilitating
dissociation of CaM. In addition, emission ratios from
YFP-T286D with CFP-CaM and YFP-T286D-CFP was
simultaneously increased or decreased, respectively, fol-
lowing ionomycin application and then returned to base-
line, indicating that the T286D mutant exhibited only
CaM-dependent conformational change (Figure 6C, D).
However, these observations do not mean that YFP-
T286D-CFP fails to form CaM-independent (T286-phos-
phorylation-dependent) conformational change because
it is thought that the T286D mutant had already formed
similar conformation with the T286-phosphorylated
form of αCaMKII at baseline levels. More importantly,
the observed reduction in emission ratio from YFP-
T286D-CFP following ionomycin application suggests
that the interaction with CaM leads to the further con-
formational change of this mutant. Therefore, this obser-
vation also suggests that T286-phosphorylated αCaMKIIdisplays similar but distinct conformation with CaM-
bound αCaMKII.
We finally examined the effects of mutations at T305/
306 to A. In contrast to the results obtained with T286
mutants, we observed a higher emission ratio from YFP-
T305/306A with CFP-CaM compared to control fusion
protein (Figure 6E, F). Since phosphorylation at T305/
306 enhances the dissociation of CaM, this increased
emission ratio may reflect an increased number of
complexes formed by YFP-T305/306A with CFP-CaM.
Consistently, lower emission ratios from YFP-T305/
306A-CFP were observed compared to control fusion
protein during which emission ratios from YFP-T305/
306A with CFP-CaM was increased (Figure 6E, F). Inter-
estingly, the addition of T305/306A mutations into the
T286A mutant (T286/305/306A) rescued impairments
in the interaction with CaM observed with the T286A
mutant (Figure 6G, H), although this T286/305/306A
mutant failed to exhibit CaM-independent conform-
ational change. Therefore, this mutant is thought to ex-
hibit normal ability to interact with CaM and to adopt
CaM-dependent conformational change, but lacks CaM-
independent conformational change (Figure 6G, H). It is
important to note that mutant proteins exhibited
comparable expression levels with YFP-αCaMKII-CFP in
the presence and absence of drugs (Additional file 2:
Figure S2).
αCaMKII is known to play essential roles in LTP and
memory, and functions as a memory molecule enabling
the maintenance of kinase activity by changing from a
CaM-dependent active form to a CaM-independent
(T286-phosphorylated) active form, even after Ca2+/CaM
dissociation. In the present study, to understand the mo-
lecular dynamics of αCaMKII activation via interaction
with CaM and the phosphorylation of αCaMKII, we gener-
ated YFP-αCaMKII, CFP-CaM and YFP-αCaMKII-CFP
and using these probes, performed real-time imaging of
both αCaMKII-CaM interaction and the conformational
change of αCaMKII in living cells in response to increases
in intracellular Ca2+ concentration. Our results indicated
that changes in intracellular Ca2+ concentration tightly
correlate with that of emission ratio from YFP-αCaMKII
with CFP-CaM (Figures 3, 4 and 5); intracellular Ca2+ con-
centration and the observed emission ratios increased
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ing that the complex formation of αCaMKII and CaM
depended upon the intracellular concentration of Ca2+. Fur-
thermore, changes in emission ratios from YFP-αCaMKII
with CFP-CaM and YFP-αCaMKII-CFP were inversely cor-
related with increasing intracellular Ca2+ levels and during
periods when high intracellular Ca2+ concentration was
maintained (Figures 3, 4 and 5), indicating that YFP-
αCaMKII-CFP exhibited CaM-dependent conformational
change at this stage. In contrast, decreased emission ratio
from YFP-αCaMKII-CFP did not return to the baseline andFigure 6 Effects of mutations at T286/305/306 upon the molecular dy
mutants. Graphs show relative YFP/CFP emission ratio (open circle, αCaMKI
bar shows the period of ionomycin application. (A, B) T286A. (C, D) T286D
αCaMKII with CaM. (B, D, F, H) Conformational change of αCaMKII. 20–30 cwas maintained at constant levels even when the emission
ratios from YFP-αCaMKII with CFP-CaM returned to
baseline when Ca2+ signaling was highly active. These ob-
servations indicate that YFP-αCaMKII-CFP exhibits CaM-
independent (perhaps, T286-phosphorylation dependent)
conformational change at this stage. Thus, we observed the
transfer of conformational change of YFP-αCaMKII-CFP
from a CaM-dependent form into a CaM-independent
form when intracellular Ca2+ concentration was first in-
creased to high levels and then subsequently decreased.
Consequently, our current observations strongly supportnamics of αCaMKII in SH-SY5Y cells. Time lapse imaging of αCaMKII
I mutant fusion proteins; filled circle, WT αCaMKII fusion proteins). Black
. (E, F) T305/306A. (G, H) T286/305/306A. (A, C, E, G) Interaction of
ells were analyzed in each group.
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independent conformational change, even after the
dissociation of CaM [6,17].
As described above, our findings that decreased emis-
sion ratios from YFP-αCaMKII-CFP were increased fol-
lowing a reduction in Ca2+ concentration in SH-SY5Y
cells, or after drug wash out in HeLa cells and cortical
neurons, but did not return to baseline suggests that the
CaM-dependent conformation of YFP-αCaMKII-CFP ex-
hibits less FRET compared to CaM-independent con-
formation. This observation suggests that CaM-bound
and CaM-unbound (but T286-phosphorylated) active
forms of αCaMKII exhibit distinct conformations, or dif-
ferences in their conformation such as the distance or
angle between CFP and YFP. Interestingly, YFP-T286D-
CFP displayed reductions in emission ratio only during
when YFP-T286D interacted with CFP-CaM. These
observations strongly support our conclusion that
differences in the observed emission ratios between
CaM-dependent and -independent active forms of YFP-
αCaMKII-CFP reflect differences in their conformation.
Therefore, our observations raise the possibility that
CaM-dependent and -independent active forms also ex-
hibit differences not only in their conformation but also
in their function, such as the interaction of αCaMKII
with other proteins including GluN2B, which play critical
roles in LTP and memory. Further studies are required to
investigate functional differences between CaM-dependent
and independent active forms of αCaMKII.
Mutation of T286 to an A residue resulted in reduced
interaction with CaM. This observation strongly suggests
that phosphorylation at T286 plays regulatory roles in
the interaction with CaM, as well as CaM-independent
conformational change, and supports previous predic-
tions that phosphorylation at T286 stabilizes interactions
with CaM. On the other hand, T305/306A mutations
resulted in increased interaction with CaM. This obser-
vation is also consistent with previous predictions and
indicates that in contrast to T286, T305/306 plays in-
hibitory roles in terms of CaM interactions. Notably, our
observations that triple mutations at T286/305/306
counter-balanced the effects of T286A and T305/306A
mutations provided significant support for our conclu-
sions that T286 and T305/306 mutations play positive
and negative roles, respectively, with respect to CaM
interaction. Thus phosphorylation at T286 and T305/
306 mediate the strength of Ca2+ signaling activation by
regulating interactions with CaM and conformational
change, and by determining the duration of αCaMKII-
activation in vivo.
Conclusions
In summary, we demonstrated the molecular dynamics
of αCaMKII activation via the transition from CaM-dependent to -independent active forms. Future studies
now required to investigate the molecular mechanisms
underlying the formation of LTP and memory by moni-
toring αCaMKII activation in a real-time manner using
the molecular probes developed in this study. Furthermore,
our molecular probes could be applied to identify thera-
peutic targets for cognitive disorders such as Angelman




The full-length cDNA encoding mouse αCaMKII was
amplified by PCR using cDNA from the whole brain of
C57B/6 mouse as a template with the following primers:
forward primer, ggg tct aga tgt aca aga tgg cta cca tca
cct gc, and reverse primer, ggg ggt acc ggg ccc atg cgg
cag gac gga ggg. The resulting PCR fragment was sub-
cloned into the XbaI-KpnI sites of pBluescriptII (SK–)
(Stratagene), generating pBS-αCaMKII. To generate full-
length cDNA encoding T286A and D, and T305/306A,
two separate fragments (nucleotides 1 to 858 and 859 to
1437, and 1 to 945 and 859 to 1437, respectively, in
αCaMKII) were amplified by PCR using pBS-αCaMKII
as a template with the following primers: 1/858 forward
primer, ggg tct aga tgt aca aga tgg cta cca tca cct gc, and
1/858 T286A reverse primer, ggg gga tcc gtc gac ggc ctc
ctg tct gtg cat gca, or 1/858 T286D reverse primer, ggg
gga tcc gtc gac gtc ctc ctg tct gtg cat gca (mutated se-
quences are boxed); 859/1437 forward primer, ggg gga
tcc gtc gac tgc ctg aag aag ttc, and 859/1437 reverse pri-
mer, ggg ggt acc ggg ccc atg cgg cag gac gga ggg; 1/945
forward primer, ggg tct aga tgt aca aga tgg cta cca tca
cct, and 1/945 reverse primer, ggg gaa ttc tcc gga gaa gtt
cct ggt ggc cag cat cag cag gag gat ggc tcc ctt cag (mu-
tated sequences are boxed); 945/1437 forward primer,
ggg gga tcc tcc gga ggg aag agc gga, and 945/1437 re-
verse primer, ggg ggt acc ggg ccc atg cgg cag gac gga
ggg. To ligate the two fragments, we made use of SalI or
BspEI restriction sites that we had introduced at the 3′
and 5′ ends of the coding region by amplification with
the above primers (see sequences in bold). The full
length T286A, T286D or T305/306A mutant sequences
comprising the two ligated PCR fragments were inserted
into the XbaI-KpnI sites of pBluescriptII (SK–), generat-
ing pBS-T286A, pBS-T286D and pBS-T305/306A,
respectively. The XbaI-ApaI fragment encoding WT-
αCaMKII from pBS-αCaMKII was subsequently sub-
cloned into pcDNA3 (Invitrogen), generating a plasmid
expressing WT-αCaMKII (pWT-αCaMKII). The BsrGI-
ApaI fragment encoding αCaMKII from pBS-αCaMKII
was sub-cloned into pEYFP-C1 (CLONTECH), generating
a plasmid expressing YFP-αCaMKII (pYFP-αCaMKII). The
full-length cDNA encoding CFP was amplified by PCR
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lowing primers: forward primer, ggg ggt acc ggg ccc atg gtg
agc aag ggc, and reverse primer, ggg gga tcc tca ctt gta cag
ctc gtc cat. The resulting PCR fragment was then
sub-cloned into the ApaI-BamHI sites of pYFP-αCaMKII,
generating a plasmid expressing YFP-αCaMKII-CFP
(pYFP-αCaMKII-CFP). Using similar procedures, pYFP-
T286A, pYFP-T286D, pYFP-T305/306A, pYFP-T286A-
CFP, pYFP-T286D-CFP and pYFP-T305/306A-CFP were
generated, respectively. Using similar procedure with that
of mouse αCaMKII, the full-length cDNA encoding mouse
CaM was amplified by PCR as a template with the follow-
ing primers: forward primer, ggg tcc gga atg gct gat cag ctg
act, and reverse primer, ggg gaa ttc ttt tgc agt cat cat ctg.
The resulting PCR fragment was subcloned into the BspEI-
EcoRI sites of pECFP-C1, generating a plasmid expressing
CFP-CaM (pCFP-CaM). To generate the plasmids
expressing YFP-T286/305/306A or YFP-T286/305/
306A-CFP (pYFP-T286/305/306A and pYFP-T286/305/
306A-CFP), the BsrGI-SalI fragment encoding T286A from
pYFP-T286A was sub-cloned into pYFP-T305/306 or
pYFP-T305/306A-CFP, respectively.
Cell culture and transient transfection
As described previously [38,39], cultured cells were
maintained at 37°C in 95% O2 5% CO2 in Dulbecco’s modi-
fied Eagle’s medium (DMEM, NISSUI) supplemented with
penicillin (100 U/ml) streptomycin (100 mg/ml) and 5%
(HeLa cells and COS-1 cells) or 10 % (SH-SY5Y cells) fetal
bovine serum (FBS, JRH BIOSCIENCE), respectively, and
transiently transfected. Similarly, rat brain cortical neurons
(CAMBREX) were maintained in Neuro basal medium
(Invitrogen) supplemented with Penicillin-Streptomycin
Mixture (TaKaRa), 200 mM L-Glutamine and B27
Supplement (Invitrogen). Rat cortical neurons or, HeLa
cells, COS-1 cells or SH-SY5Y cells grown in a 35 mm
glass-bottom culture dish with or without coating by
poly-D-lysine (Mat Tek) were transiently transfected with
pYFP-αCaMKII (3 or 1 μg) and pCFP-CaM (3 or 1 μg), or
pYFP-αCaMKII-CFP (6 or 2 μg) using Lipofectamine™ and
Nupherin™ (BIOMOL international) or PLUS™ Reagent
and Lipofectamine™ (Invitrogen), respectively. Solu-
tions of drugs were dissolved in DMSO at 1 mM
[ionomycin (SIGMA), KN-93 (CALBIOCHEM), KN-92
(CALBIOCHEM) and AP5 (SIGMA)], or water at 1 M
(KCl) or 100 mM [NMDA (SIGMA)]. These stock so-
lutions were diluted into Hanks Balanced Salt Solution
(HBSS) and added to the cell cultures.
FRET analysis
FRET based analyses were performed as previously de-
scribed [40]. Twenty-four hrs after the transfection, cells
were washed two times in HBSS and incubated for 30
min at 37°C. For the FRET-based time-lapse imaging,YFP emissions at 535 nm and the CFP emissions at 480
nm were recorded every 30 sec using excitation at 440
nm. Relative emission ratio was calculated using the
following formula: emission ratio at each time point/
emission ratio at time −1 min. The range of emission
ratio was between 1.3 (maximum) and 0.6 (minimum).
Emission ratio images were presented in pseudo-color in
which the red range indicates high emission ratio and
the blue range indicates low emission ratio. FRET effi-
ciency was calculated using the following formula: 1 –
(Fda/Fd). Fd and Fda represent donor emission intensity
before and after acceptor photo-bleaching, respectively.
Ca2+ imaging
Cells were loaded with Fura2-AM (1 μg, DOJINDO) at
37°C for 30 min, and then washed four times with HBSS.
Fluorescence was monitored as above (FRET analysis)
using specific filters (CHROMA). For time-lapse im-
aging, Fura2-AM emissions at 510 nm were recorded
every 30 sec using alternative excitation at 340 or 380
nm, corresponding to bound and un-bound Ca2+ frac-
tions, respectively. The range of 340 nm/380 nm ratio
was between 0.5 (maximum) and 0.01 (minimum). 340
nm/380 nm ratio images were presented in pseudo-color
in which the red range indicates high 340 nm/380 nm
ratio and the blue range indicates low 340 nm/380 nm
ratio.
Western blotting
HeLa cells grown in a 35 mm dish were transiently
transfected with pYFP-αCaMKII (2 μg) or pYFP-
αCaMKII-CFP (2 μg). Western blotting was performed
as previously described [40]. Western blot membranes
were probed with anti-active αCaMKII phospho-T286
antibody (1:2000, PROMEGA), anti-αCaMKII antibody
(1:2000, Santa Cruz Biotechnology) or anti-β-Actin anti-
body (1:2000, SIGMA) and then visualized with
peroxidase-conjugated rabbit anti-mouse IgG (1:2000,
Santa Cruz Biotechnology).
Kinase assay
Kinase activity was measured as previously described
[17,41]. Twenty-four hrs after the transfection, cells were
homogenized in PBS on ice. Cell extracts were first pre-
incubated in reaction buffer (50 mM Tris (pH 7.5), 10
mM MgCl2, 2 mM DTT, 0.1 mM EDTA, 100 μM ATP
and 2 mM CaCl2) for 10 min at 37°C and then
autocamtide-2, a synthetic peptide which is a specific
substrate for αCaMKII, was added at final concentration
of 20 μM together with 0.4 mM (200–600 cpm/pmol) of
[γ-32P-ATP]. The reaction mixtures were incubated for 5
min at 37°C. The mixtures were characterized by spotting
15 μl of the supernatant on P-81 phosphocellulose paper
(Whatman). The spotted papers were subsequently washed
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was quantified as described using Cerenkov radiation.
Molecular weight determinations
Gel filtration was performed as previously described
[42]. COS-1 cells grown in a 100 mm dish were transi-
ently transfected with pWT-αCaMKII (8 μg), pYFP-
αCaMKII (8 μg) or pYFP-αCaMKII-CFP (8 μg). Twenty-
four hrs after the transfection, whole cell extracts were
fractured by lysis buffer containing 0.5% Nonidet-P40
(NP-40), 10 mM Na2HPO4 [pH 7.5], 150 mM KCl and 2
mM EDTA. Cell extracts were loaded onto a Sephacryl
S-300 gel filtration column (GE Healthcare) in buffer
containing 20 mM HEPES [pH 7.5], 150 mM KCl,
0.1 mM EDTA and complete EDTA-free (Roche).
Thyrogloblin (669 kDa), ferritin (440 kDa), catalase (232
kDa) and aldolase (158 kDa) were used as standards for
molecular weight determination. The elution positions
of WT-αCaMKII or αCaMKII fusion proteins were de-
termined from absorbance at 280 nm of the column ef-
fluent while collecting fractions. In order to confirm that
the identified peaks were αCaMKII proteins, the proteins
in each fraction were analyzed by Western blotting.
Additional file
Additional file 1: Figure S1. (A) Long-term imaging in HeLa cells
expressing αCaMKII fusion proteins at 30 sec intervals for 25 min. Upper
graph shows the interaction of YFP-αCaMKII with CFP-CaM. Lower graph
shows conformational change of YFP-αCaMKII-CFP. (B) Short-term
imaging in HeLa cells expressing αCaMKII fusion proteins at 1 sec
intervals for 1.5 min. Upper graph shows the interaction of YFP-αCaMKII
with CFP-CaM. Lower graph shows the conformational change of YFP-
αCaMKII-CFP. Black bars shows the period of ionomycin application (A
and B). 5–10 cells were analyzed in each group. (C) Imaging of changes
in Ca2+ concentration using Fura2-AM when HBSS perfusion was
performed at 1 min following ionomycin application. 10–20 cells were
analyzed in each group. Black bar and white bar show the period of
ionomycin application. 10–15 cells were analyzed in each group. Lower
panels show auto-phosphorylation at T286 of YFP-αCaMKII-CFP following
ionomycin application at each time point (0, 1, 5 and 10 min) with or
without of removal of ionomycin. Black bar and white bar show the
period of ionomycin application.
Additional file 2: Figure S2. Expression levels of αCaMKII fusion
proteins in HeLa cells. (A) Western blot analysis of the expression level of
αCaMKII fusion proteins. Left panel shows expression level of YFP-
αCaMKIIs and CFP-CaM (black arrow head, YFP-αCaMKIIs; white arrow
head, CFP-CaM). Right panel shows expression level of YFP-αCaMKII-CFPs
(black arrow head, YFP-αCaMKII-CFPs). (B) Effects of ionomycin
application upon the expression levels of αCaMKII fusion proteins.
Western blot analyses analyzing the expression level of αCaMKII fusion
proteins were performed using GFP specific antibody (black arrow head,
YFP-αCaMKIIs or YFP-αCaMKII-CFPs; white arrow head, CFP-CaM). β-Actin
specific antibody was used as a loading control.
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